-
Cheshire Medical Center keeps pharmacy permit, with restrictions
Cheshire Medical Center in Keene, N.H., part of Dartmouth Health, on July 28 reached a settlement with the state's pharmacy board that allows it to keep its pharmacy permit, with various restrictions that will last for three years, The Keene Sentinel reported Aug. 1. -
Nation's 1st case over right to contraception begins in Minnesota
In a post-Roe America, a Minnesota jury is tasked to decide this week whether people have the right to emergency contraception in what is thought to be the first case of its kind, according to the Star Tribune. -
Lab capacity far exceeds monkeypox tests despite rising cases
Despite labs ramping up their production to assess thousands of monkeypox tests per week, some labs are receiving a scarce number of tests, according to CNN. -
Legislators urge Walgreens to change reproductive product policy
After an alleged incident of a Walgreens worker refusing to sell condoms spurred a barrage of calls for a boycott, U.S. Sens. Dick Durbin and Tammy Duckworth of Illinois pressed the retail pharmacy to renew its policies. -
Rite Aid denies some prescriptions from telehealth startups
Rite Aid Corp. has stopped filling prescriptions for controlled substances from the telehealth startups Cerebral and Done, Bloomberg reported July 28. -
US to buy 66M doses of Moderna's omicron-targeted vaccine
HHS, in collaboration with the U.S. Department of Defense, will purchase 66 million doses of Moderna's bivalent COVID-19 vaccine booster for potential use later this year. -
Attorney general files suit accusing CVS of antitrust law violations
New York Attorney General Letitia James is suing CVS Health for allegedly violating antitrust laws and "diverting millions from underserved communities," according to a July 28 news release. -
Pfizer earned $27.7B in Q2: 3 findings
In 2022's second quarter, Pfizer reported July 28 its largest-ever quarterly sales as it racked up $27.7 billion, mostly thanks to its vaccine sales. -
90% of Americans live close to a pharmacy, analysis finds
Nearly 9 of every 10 Americans live within 5 miles of a pharmacy, and about 50 percent of the population lives within 1 mile of one, according to a preprint analysis. -
Critics say Mark Cuban's pharmacy isn't tackling the big issue: brand-name drugs
Mark Cuban's pharmacy, Cost Plus Drug Co., has hundreds of drugs marked at discounted prices, but some pharmacy experts say there's a larger problem that needs fixing, CNBC reported July 28. -
10 hospitals seeking pharmacy leaders
The following 10 hospitals, health systems and hospital operators have posted job listings seeking pharmacy leaders in the last week. -
Top 15 specialty pharmacies by revenue
CVS Health's and Cigna's specialty pharmacies make a slight majority in the nation's revenue share, and the four top companies account for 75 percent of the market share, according to the Drug Channels Institute's estimates released July 27. -
Officials push for omicron-targeted vaccines by September
Refreshed vaccines aimed at omicron subvariants BA.4 and BA.5, which account for nearly all COVID-19 infections, could be available to the public in about six weeks, according to NPR. -
Drugmakers leap back into fading heart drug market
As generics outpaced blood pressure and cholesterol medications, drugmakers initially withdrew from developing costly heart drugs but are now cautiously returning, The Wall Street Journal reported July 26. -
Former pharmacy director at New Hampshire hospital where fentanyl went missing settles with state board
Keene, N.H.-based Cheshire Medical Center's former pharmacy director, Melissa Siciliano, PharmD, must pay a $1,000 fine and participate in education courses as part of a settlement agreement reached with the state's pharmacy board July 20, The Keene Sentinel reported July 26. -
White House's vision for next-gen COVID-19 shots: 3 takeaways
The White House held a summit on the next generation of COVID-19 vaccines July 26 during which federal health experts shared their vision for a vaccine that protects against infection from multiple variants, according to U.S. News & World Report. -
Drugmaker organization launches ads lobbying against drug-pricing bill
A lobbying group that represents drugmakers including Pfizer and Johnson & Johnson aired ads slamming the drug pricing bill trudging through Congress, The Hill reported July 25. -
A month after Roe reversal, demand for abortion pills remains high
Requests for abortion pills saw a 109 percent increase between June 24 and July 15, nonprofit organization Just the Pill told Becker's. -
COVID-19 vaccines and omicron: 2 new findings
As omicron subvariant BA.5 prompts a summer surge in COVID-19 cases, here are two recent studies on vaccine effectiveness against the quickly spreading variant: -
COVID-19 vaccines for children under 5: A state breakdown
The effort to vaccinate children younger than 5 has crawled since its infancy, with CDC data showing less than 3 percent of the nation's 19 million children in this age group with at least one vaccine jab.
Page 44 of 50